Abbott stock powers through 100-DMA, but long-term downtrend still looms (ABT:NYSE)


Illinois Drugmaker Under Investigation By State Attorney General

Tim Boyle/Getty Images News

Abbott Laboratories (ABT) shares are experiencing a massive technical shift in Thursday afternoon trading, surging over 10% on the heels of better-than-expected second-quarter 2026 earnings and a boosted full-year outlook. The daily chart reveals a compelling technical setup as



Source link

4K Blu-ray makes a huge difference when you’re watching this specific film genre

Jelly Roll Wants a ‘Tradwife’ Now, Says Brianna Chickenfry

Leave a Reply

Your email address will not be published. Required fields are marked *